FDA Approved: TERCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for terconazole by E. Fougera & Co. to update labeling for the antifungal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Terconazole (Terconazole)

Snippet

SUPPL AP for TERCONAZOLE (TERCONAZOLE)